This is not the most recent version of the article. View current version (24 APR 2014)

Intervention Protocol

You have free access to this content

Immune tolerance induction for treating inhibitors in people with congenital haemophilia A or B

  1. Abha H Athale1,*,
  2. Maura Marcucci2,
  3. Alfonso Iorio3

Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group

Published Online: 5 JUN 2013

Assessed as up-to-date: 10 MAY 2013

DOI: 10.1002/14651858.CD010561


How to Cite

Athale AH, Marcucci M, Iorio A. Immune tolerance induction for treating inhibitors in people with congenital haemophilia A or B (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 6. Art. No.: CD010561. DOI: 10.1002/14651858.CD010561.

Author Information

  1. 1

    McMaster University, Department of Health Sciences, Hamilton, Ontario, Canada

  2. 2

    University of Perugia, Department of Internal Medicine, Perugia, Italy

  3. 3

    McMaster University, Clinical Epidemiology and Biostatistic Department, Hamilton, ON, Canada

*Abha H Athale, Department of Health Sciences, McMaster University, 1280 Main Street West, Hamilton, Ontario, L8S 4L8, Canada. athaleah@mcmaster.ca.

Publication History

  1. Publication Status: New
  2. Published Online: 5 JUN 2013

SEARCH

This is not the most recent version of the article. View current version (24 APR 2014)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To determine the efficacy and adverse effects of ITI in persons with congenital haemophilia A and B.